Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015 (2015), Article ID 497431, 12 pages
http://dx.doi.org/10.1155/2015/497431
Research Article

Euglycemia in Diabetic Rats Leads to Reduced Liver Weight via Increased Autophagy and Apoptosis through Increased AMPK and Caspase-3 and Decreased mTOR Activities

1Department of Biochemistry, School of Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of Korea
2Department of Internal Medicine, School of Medicine, Konkuk University, Chungju Hospital, 82 Kukwondae-ro, Chungju 380-704, Republic of Korea
3Rmedica-Stem Cell, 98 Gasan Digital 2-ro, Geumcheon-gu, Seoul 153-768, Republic of Korea
4Department of Neurology, School of Medicine, Konkuk University, Chungju Hospital, 82 Kukwondae-ro, Chungju 380-704, Republic of Korea
5Department of Physiology, College of Medicine, Chung-Ang University, 84 Heukseouk-ro, Dongjak-gu, Seoul 156-861, Republic of Korea

Received 26 December 2014; Revised 11 March 2015; Accepted 31 March 2015

Academic Editor: Ponnusamy Saravanan

Copyright © 2015 Jun-Ho Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lillioja, D. M. Mott, M. Spraul et al., “Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians,” The New England Journal of Medicine, vol. 329, no. 27, pp. 1988–1992, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. S. E. Kahn, “The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes,” Diabetologia, vol. 46, no. 1, pp. 3–19, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. I. M. Stratton, A. I. Adler, H. A. W. Neil et al., “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study,” British Medical Journal, vol. 321, no. 7258, pp. 405–412, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Klein, B. E. K. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, “Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy,” The Journal of the American Medical Association, vol. 260, no. 19, pp. 2864–2871, 1988. View at Publisher · View at Google Scholar · View at Scopus
  5. R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. A. W. Neil, “10-Year follow-up of intensive glucose control in type 2 diabetes,” The New England Journal of Medicine, vol. 359, no. 15, pp. 1577–1589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. H. A. Karunajeewa, I. Mueller, M. Senn et al., “A trial of combination antimalarial therapies in children from Papua New Guinea,” The New England Journal of Medicine, vol. 359, no. 24, pp. 2545–2557, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. J. Currie, J. R. Peters, A. Tynan et al., “Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study,” The Lancet, vol. 375, no. 9713, pp. 481–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Inzucchi, R. M. Bergenstal, J. B. Buse et al., “Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD),” Diabetes Care, vol. 35, no. 6, pp. 1364–1379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Publisher · View at Google Scholar
  10. P. Reichard, B.-Y. Nilsson, and U. Rosenqvist, “The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 5, pp. 304–309, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. H. C. Gerstein, J. Pogue, J. F. E. Mann et al., “The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis,” Diabetologia, vol. 48, no. 9, pp. 1749–1755, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Lee, M. Jin, S. Han et al., “Diet control to achieve euglycemia induces significant loss of heart and liver weight via increased autophagy compared with ad libitum diet in diabetic rats,” Experimental & Molecular Medicine, vol. 46, no. 8, p. e111, 2014. View at Publisher · View at Google Scholar
  13. Y.-H. Noh, W.-J. Lee, K.-A. Kim et al., “Insulin requirement profiles of patients with type 2 diabetes after achieving stabilized glycemic control with short-term continuous subcutaneous insulin infusion,” Diabetes Technology and Therapeutics, vol. 12, no. 4, pp. 271–281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. de Marco, F. Locatelli, G. Zoppini, G. Verlato, E. Bonora, and M. Muggeo, “Cause-specific mortality in type 2 diabetes: the Verona Diabetes Study,” Diabetes Care, vol. 22, no. 5, pp. 756–761, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. J. D. Rabinowitz and E. White, “Autophagy and metabolism,” Science, vol. 330, no. 6009, pp. 1344–1348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Efeyan and D. M. Sabatini, “mTOR and cancer: many loops in one pathway,” Current Opinion in Cell Biology, vol. 22, no. 2, pp. 169–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Wu, K. Senechal, M. S. Neshat, Y. E. Whang, and C. L. Sawyers, “The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 26, pp. 15587–15591, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Espert, M. Denizot, M. Grimaldi et al., “Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4,” The Journal of Clinical Investigation, vol. 116, no. 8, pp. 2161–2172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. C. Maiuri, E. Zalckvar, A. Kimchi, and G. Kroemer, “Self-eating and self-killing: crosstalk between autophagy and apoptosis,” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 741–752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. R. C. Scott, G. Juhász, and T. P. Neufeld, “Direct induction of autophagy by Atg1 inhibits cell growth and induces apoptotic cell death,” Current Biology, vol. 17, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Barsotti, F. Ciardella, E. Morelli, A. Cupisti, A. Mantovanelli, and S. Giovannetti, “Nutritional treatment of renal failure in type 1 diabetic nephropathy,” Clinical Nephrology, vol. 29, no. 6, pp. 280–287, 1988. View at Google Scholar · View at Scopus
  22. J. D. Walker, J. J. Bending, R. A. Dodds et al., “Restriction of dietary protein and progression of renal failure in diabetic nephropathy,” The Lancet, vol. 2, no. 8677, pp. 1411–1415, 1989. View at Google Scholar · View at Scopus
  23. F. J. Raal, W. J. Kalk, M. Lawson et al., “Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6-mo prospective study,” The American Journal of Clinical Nutrition, vol. 60, no. 4, pp. 579–585, 1994. View at Google Scholar · View at Scopus
  24. T. H. Hostetter, T. W. Meyer, H. G. Rennke, and B. M. Brenner, “Chronic effects of dietary protein in the rat with intact and reduced renal mass,” Kidney International, vol. 30, no. 4, pp. 509–517, 1986. View at Publisher · View at Google Scholar · View at Scopus
  25. T. H. Hostetter, J. L. Olson, H. G. Rennke, M. A. Venkatachalam, and B. M. Brenner, “Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation,” The American Journal of Physiology, vol. 241, no. 1, pp. F85–F93, 1981. View at Google Scholar · View at Scopus
  26. E. H. Baehrecke, “Autophagy: dual roles in life and death?” Nature Reviews Molecular Cell Biology, vol. 6, no. 6, pp. 505–510, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Martinet, G. R. Y. de Meyer, L. Andries, A. G. Herman, and M. M. Kockx, “In situ detection of starvation-induced autophagy,” Journal of Histochemistry and Cytochemistry, vol. 54, no. 1, pp. 85–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Franko, J. C. von Kleist-Retzow, M. Böse et al., “Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle,” Journal of Molecular Medicine, vol. 90, no. 10, pp. 1145–1160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. W. J. Ellingson, D. G. Chesser, and W. W. Winder, “Effects of 3-phosphoglycerate and other metabolites on the activation of AMP-activated protein kinase by LKB1-STRAD-MO25,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 292, no. 2, pp. E400–E407, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. J. Lum, D. E. Bauer, M. Kong et al., “Growth factor regulation of autophagy and cell survival in the absence of apoptosis,” Cell, vol. 120, no. 2, pp. 237–248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Inoki, T. Zhu, and K.-L. Guan, “TSC2 mediates cellular energy response to control cell growth and survival,” Cell, vol. 115, no. 5, pp. 577–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Eisenberg-Lerner, S. Bialik, H. U. Simon, and A. Kimchi, “Life and death partners: apoptosis, autophagy and the cross-talk between them,” Cell Death and Differentiation, vol. 16, no. 7, pp. 966–975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Rogacka, A. Piwkowska, I. Audzeyenka, S. Angielski, and M. Jankowski, “Involvement of the AMPK-PTEN pathway in insulin resistance induced by high glucose in cultured rat podocytes,” The International Journal of Biochemistry and Cell Biology, vol. 51, no. 1, pp. 120–130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Settembre, C. Di Malta, V. A. Polito et al., “TFEB links autophagy to lysosomal biogenesis,” Science, vol. 332, no. 6036, pp. 1429–1433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Settembre, R. de Cegli, G. Mansueto et al., “TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop,” Nature Cell Biology, vol. 15, no. 6, pp. 647–658, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. P.-E. Rautou, D. Cazals-Hatem, R. Moreau et al., “Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy,” Gastroenterology, vol. 135, no. 3, pp. 840.e3–848.e3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Grewal, S. Kamili, and D. Motamed, “Chronic hepatitis E in an immunocompetent patient: a case report,” Hepatology, vol. 59, no. 1, pp. 347–348, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Basevi, S. Di Mario, C. Morciano, F. Nonino, and N. Magrini, “Comment on: American Diabetes Association. Standards of medical care in diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11-S61,” Diabetes Care, vol. 34, no. 5, p. e53, 2011. View at Publisher · View at Google Scholar
  39. J. P. Bantle, J. Wylie-Rosett, A. L. Albright et al., “Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association,” Diabetes Care, vol. 3, supplement 1, pp. S61–S78, 2008. View at Google Scholar
  40. A. R. Gosmanov, F. B. Stentz, and A. E. Kitabchi, “De novo emergence of insulin-stimulated glucose uptake in human aortic endothelial cells incubated with high glucose,” American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 3, pp. E516–E522, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Pekala, M. Marlow, D. Heuvelman, and D. Connolly, “Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-α, but not by insulin,” The Journal of Biological Chemistry, vol. 265, no. 30, pp. 18051–18054, 1990. View at Google Scholar · View at Scopus
  42. B. B. Kahn, T. Alquier, D. Carling, and D. G. Hardie, “AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism,” Cell Metabolism, vol. 1, no. 1, pp. 15–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S.-Y. Li, C. X. Fang, N. S. Aberle II, B. H. Ren, A. F. Ceylan-Isik, and J. Ren, “Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function,” Journal of Endocrinology, vol. 186, no. 3, pp. 491–503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. M. M. Mariappan, M. Shetty, K. Sataranatarajan, G. G. Choudhury, and B. S. Kasinath, “Glycogen synthase kinase 3β is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells,” The Journal of Biological Chemistry, vol. 283, no. 45, pp. 30566–30575, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. R. C. Wang and B. Levine, “Autophagy in cellular growth control,” FEBS Letters, vol. 584, no. 7, pp. 1417–1426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. H. C. Gerstein, M. E. Miller, R. P. Byington et al., “Effects of intensive glucose lowering in type 2 diabetes,” The New England Journal of Medicine, vol. 358, no. 24, pp. 2545–2559, 2008. View at Publisher · View at Google Scholar · View at Scopus